Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1881 1
1882 1
1883 2
1885 1
1886 1
1887 1
1916 1
1946 1
1947 3
1948 1
1950 1
1951 2
1952 2
1953 3
1954 4
1955 1
1956 2
1957 1
1958 4
1959 1
1960 2
1961 3
1962 2
1963 1
1964 3
1965 1
1967 2
1968 2
1969 3
1970 1
1971 6
1972 2
1973 5
1974 2
1975 6
1976 4
1977 2
1978 4
1979 3
1980 3
1981 3
1982 4
1983 6
1984 4
1985 6
1986 3
1987 8
1988 4
1989 9
1990 3
1991 9
1992 3
1993 7
1994 4
1995 5
1996 20
1997 8
1998 11
1999 16
2000 14
2001 16
2002 16
2003 19
2004 18
2005 18
2006 21
2007 30
2008 34
2009 15
2010 17
2011 22
2012 34
2013 29
2014 41
2015 33
2016 44
2017 46
2018 45
2019 37
2020 53
2021 47
2022 52
2023 10
Text availability
Article attribute
Article type
Publication date

Search Results

863 results
Results by year
Filters applied: . Clear all
Page 1
Role of androgen receptor splice variant-7 (AR-V7) in prostate cancer resistance to 2nd-generation androgen receptor signaling inhibitors.
Zhu Y, Dalrymple SL, Coleman I, Zheng SL, Xu J, Hooper JE, Antonarakis ES, De Marzo AM, Meeker AK, Nelson PS, Isaacs WB, Denmeade SR, Luo J, Brennen WN, Isaacs JT. Zhu Y, et al. Among authors: hooper je. Oncogene. 2020 Nov;39(45):6935-6949. doi: 10.1038/s41388-020-01479-6. Epub 2020 Sep 28. Oncogene. 2020. PMID: 32989253 Free PMC article.
Open-label randomised pragmatic trial (CONTACT) comparing naproxen and low-dose colchicine for the treatment of gout flares in primary care.
Roddy E, Clarkson K, Blagojevic-Bucknall M, Mehta R, Oppong R, Avery A, Hay EM, Heneghan C, Hartshorne L, Hooper J, Hughes G, Jowett S, Lewis M, Little P, McCartney K, Mahtani KR, Nunan D, Santer M, Williams S, Mallen CD. Roddy E, et al. Among authors: hooper j. Ann Rheum Dis. 2020 Feb;79(2):276-284. doi: 10.1136/annrheumdis-2019-216154. Epub 2019 Oct 30. Ann Rheum Dis. 2020. PMID: 31666237 Free PMC article. Clinical Trial.
Resistance to androgen receptor signaling inhibition does not necessitate development of neuroendocrine prostate cancer.
Brennen WN, Zhu Y, Coleman IM, Dalrymple SL, Antony L, Patel RA, Hanratty B, Chikarmane R, Meeker AK, Zheng SL, Hooper JE, Luo J, De Marzo AM, Corey E, Xu J, Yegnasubramanian S, Haffner MC, Nelson PS, Nelson WG, Isaacs WB, Isaacs JT. Brennen WN, et al. Among authors: hooper je. JCI Insight. 2021 Apr 22;6(8):e146827. doi: 10.1172/jci.insight.146827. JCI Insight. 2021. PMID: 33724955 Free PMC article.
Cancer-on-a-Chip: Models for Studying Metastasis.
Zhang X, Karim M, Hasan MM, Hooper J, Wahab R, Roy S, Al-Hilal TA. Zhang X, et al. Among authors: hooper j. Cancers (Basel). 2022 Jan 27;14(3):648. doi: 10.3390/cancers14030648. Cancers (Basel). 2022. PMID: 35158914 Free PMC article. Review.
863 results